NICE final ‘yes’ for Biogen’s MS pill
August 27, 2014Sales and Marketing Aubagio, Biogen, RMS, RRMS, gilenya
In final guidance published today NICE has recommended NHS funding of Biogen Idec’s new multiple sclerosis pill in patients with …
Merck Serono breaks ground in China with new plant
August 27, 2014Manufacturing and Production, Sales and Marketing China, Merck Serono, manufacturing, metformin
Merck Serono has broken ground for its new pharmaceutical manufacturing facility in Nantong, China. The new facility, which will be …
US rivals Pfizer and Merck team up for lung cancer
August 27, 2014Medical Communications, Research and Development, Sales and Marketing Merck, NSCLC, Roche, Xalkori, melanoma, pembrolizumab
The two biggest rival US pharma firms have joined forces to help develop a new combination treatment for certain non-small …
UK nurse with Ebola given new drug in London
August 27, 2014Medical Communications, Research and Development, Sales and Marketing Africa, Ebola, zmapp
A British nurse was this weekend flown to a London hospital and is now being given an experimental drug after …
Miriam Monge to join Sartorius Stedim Biotech
August 26, 2014Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Sartorius Stedim Biotech (SSB), a pharma and biotech supplier, today announced the appointment of Miriam Monge as director of marketing …
AstraZeneca and Illumina in new partnership
August 26, 2014Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, Illumina, NGS technology, next generation sequencing
AstraZeneca has announced that it will develop next generation sequencing (NGS) for companion diagnostic tests in a new partnership with …
AZ launches US digital tool ‘DoctorsNotes’ in US
August 26, 2014Medical Communications, Sales and Marketing AstraZeneca, CME, CPD, apps, digital
AstraZeneca has launched a new online tool in the US called DoctorsNotes to help medical professionals keep better up to …
Merck and Advaxis team up on immuno-oncology
August 26, 2014Manufacturing and Production, Medical Communications, Research and Development ASCO, Merck, immunology, pd-1, pembrolizumab
Advaxis and Merck have signed a research deal to investigational Merck’s PD-1 inhibitor pembrolizumab in combination with Advaxis’ listeria-based cancer …
Asterias Biotherapeutics adds two to board
August 26, 2014Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Asterias Biotherapeutics, Pfizer
US biotech firm Asterias Biotherapeutics has confirmed the appointments of Andrew Arno and Natale Ricciardi to its board of directors. …
NICE and market access: time for reform?
August 26, 2014Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Bristol-Myers Squibb, NICE, Yervoy, reform
Earlier in the year, at the ABPI’s annual conference, the UK pharma lobby group released a new report suggesting that …
Roche pays $8.3bn for InterMune
August 26, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Genentech, IPF, Illumina, InterMune, Roche
Roche has stumped up $8.3 billion in cash to pay for US biotech firm InterMune and will gain access to …
Pfizer/BMS blood thinner gains new licence
August 22, 2014Sales and Marketing BMS, DVT, Eliquis, Pfizer, Pradaxa, Xarelto, blood, warfarin
Pfizer and Bristol-Myers Squibb have been handed a much-needed lift after its new blood thinner Eliquis gained a licence extension …
AstraZeneca shores up defences against Pfizer
August 22, 2014Medical Communications, Sales and Marketing AstraZeneca, Pfizer, Read, Soriot, deal, merger
AstraZeneca has been making a series of big deals over the past three months as it looks to close the …
ELC Group names new senior head
August 22, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Siddharth Chachad, elf group
UK regulatory affairs provider the ELC Group has confirmed the appointment of clinical pharmacologist Dr Siddharth Chachad as its head …
Wellcome Trust makes Ebola research investment
August 21, 2014Research and Development, Sales and Marketing Africa, Ebola, Nigeria, deltas, welcome trust
The Wellcome Trust is launching a new multimillion pound initiative for emergency Ebola research coupled with a £40 million investment …
Celebrity-endorsed drug ads don’t work, says research
August 21, 2014Medical Communications, Sales and Marketing advertising, bon jovi, dtc, healthcare marketing, paula deen, pharma
New research reveals the US system of using celebrity-endorsed drug adverts offer treatments more credibility but not influence when it …
Masters Speciality Pharma hires head from Idis
August 21, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing masters speciality pharma, warren crawford
Masters Speciality Pharma has appointed Warren Crawford as a partner development director to lead and implement creative deal structures for …
GPs admit to wrongly prescribing antibiotics
August 20, 2014Medical Communications, Sales and Marketing GPs, UK, doctors, longitude, prescribing, prize
Nearly half of British GPs surveyed have admitted to prescribing antibiotics unnecessarily due to uncertainty and a lack of diagnostic …
AZ and Mitsubishi partner on diabetic nephropathy
August 20, 2014Research and Development, Sales and Marketing AstraZeneca, BMS, Mitsubishi, cvmd, diabetes, nephropathy
AstraZeneca and Japanese firm Mitsubishi Tanabe Pharma Corporation (MTPC) have signed a new three-year research deal in the area of …
FDA approves Sanofi’s new rare disease drug
August 20, 2014Research and Development, Sales and Marketing Elelyso, Gaucher disease, Genzyme, Sanofi, eliglustat
Sanofi’s biologics unit Genzyme has been granted approval for a new drug to treat the rare genetic disorder Gaucher’s disease. …
Latest content
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
